Lavipharm S.A. (ATH:LAVI)
Greece
· Delayed Price · Currency is EUR 0.7840
-0.0080 (-1.01%)
Apr 4, 2025, 10:40 AM EET
Lavipharm Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | - | 1.87 | 0.83 | 1.72 | 2.09 | Upgrade
|
| Depreciation & Amortization | - | 4.29 | 1.5 | 1.43 | 1.37 | Upgrade
|
| Other Amortization | - | 0.06 | 0.21 | 0.22 | 0.2 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.41 | 0 | -0.04 | -0.03 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | -0.37 | - | -0.11 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -0.09 | 0.18 | 0.05 | -0.07 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | -0.37 | 0.63 | - | Upgrade
|
| Other Operating Activities | - | 1.97 | 4.47 | 3.26 | 2.48 | Upgrade
|
| Change in Accounts Receivable | - | -4.57 | -0.08 | -3.39 | 0.33 | Upgrade
|
| Change in Inventory | - | -4.9 | -1.94 | -0.75 | -2.34 | Upgrade
|
| Change in Accounts Payable | - | 2.49 | -1.52 | 1.04 | -1.11 | Upgrade
|
| Change in Other Net Operating Assets | - | 0.05 | 0.18 | 0.05 | -0.07 | Upgrade
|
| Operating Cash Flow | - | 0.28 | 3.35 | 4.11 | 2.85 | Upgrade
|
| Operating Cash Flow Growth | - | -91.51% | -18.57% | 44.17% | -1.49% | Upgrade
|
| Capital Expenditures | - | -4.12 | -35.62 | -1.92 | -1.48 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.41 | 0 | 0.01 | - | Upgrade
|
| Other Investing Activities | - | 0.25 | 0.02 | 0.02 | 0 | Upgrade
|
| Investing Cash Flow | - | -3.46 | -35.59 | -1.88 | -1.47 | Upgrade
|
| Long-Term Debt Issued | - | 54.34 | 25.18 | 14.77 | 4.7 | Upgrade
|
| Long-Term Debt Repaid | - | -60.97 | -25.62 | -17.29 | -5.88 | Upgrade
|
| Net Debt Issued (Repaid) | - | -6.63 | -0.44 | -2.52 | -1.18 | Upgrade
|
| Issuance of Common Stock | - | - | 49.29 | - | - | Upgrade
|
| Other Financing Activities | - | -0 | - | - | - | Upgrade
|
| Financing Cash Flow | - | -6.63 | 48.85 | -2.52 | -1.18 | Upgrade
|
| Net Cash Flow | - | -9.81 | 16.6 | -0.29 | 0.2 | Upgrade
|
| Free Cash Flow | - | -3.83 | -32.27 | 2.19 | 1.37 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 59.53% | 188.05% | Upgrade
|
| Free Cash Flow Margin | - | -7.53% | -82.63% | 5.52% | 3.65% | Upgrade
|
| Free Cash Flow Per Share | - | -0.02 | -1.50 | 0.13 | 0.08 | Upgrade
|
| Cash Interest Paid | - | 2.05 | 1.54 | 1.82 | 1.86 | Upgrade
|
| Cash Income Tax Paid | - | 0.26 | 0.04 | 0.06 | 0.06 | Upgrade
|
| Levered Free Cash Flow | - | -4.74 | -30.36 | 2.62 | 0.53 | Upgrade
|
| Unlevered Free Cash Flow | - | -3.37 | -29.91 | 3.76 | 1.73 | Upgrade
|
| Change in Net Working Capital | - | 6.35 | -1.46 | -1.21 | 1.59 | Upgrade
|
Updated Sep 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.